✦ LIBER ✦

Hepatitis C virus kinetics during the first phase of pegylated interferon-α-2b with ribavirin therapy in patients with living donor liver transplantation

✍ Scribed by Tatsuki Ichikawa; Kazuhiko Nakao; Hisamitsu Miyaaki; Susumu Eguchi; Mitsuhisa Takatsuki; Masumi Fujimito; Motohisa Akiyama; Satoshi Miuma; Eisuke Ozawa; Hidetaka Shibata; Shigeyuki Takeshita; Takashi Kanematsu; Katsumi Eguchi

Book ID: 118088149
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 222 KB
Volume: 39
Category: Article
ISSN: 1386-6346
DOI: 10.1111/j.1872-034x.2009.00524.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus viral kinetics during

Hepatitis C virus viral kinetics during α-2a or α-2b pegylated interferon plus ribavirin therapy in liver transplant recipients with different immunosuppression regimes

✍ Marina Berenguer; Cecilia Ortíz-Cantó; Juan José Abellán; Victoria Aguilera; Ang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 905 KB

Combined treatment with pegylated interf

Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation

✍ Lluís Castells; Víctor Vargas; Helena Allende; Itxarone Bilbao; José Luis Lázaro 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Investigation of hyperuricemia during pe

Investigation of hyperuricemia during pegylated-interferon-α2b plus ribavirin combination therapy in patients with chronic hepatitis C

✍ Naoki YAMASHITA; Munechika ENJOJI; Kazuhiro KOTOH; Masaki KATO; Akihiro UEDA; Yu 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 122 KB

Impact of pegylated interferon α-2B and

Impact of pegylated interferon α-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series

✍ Sandeep Mukherjee; Elizabeth Lyden 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Early clearance kinetics of hepatitis C

Early clearance kinetics of hepatitis C virus (HCV) in patients with chronic hepatitis C under therapy with pegylated-interferon (PEG-IFN) alpha-2b or consensus-interferon (CIFN) plus ribavirin

✍ L.C. Da Silva; S.K. Ono-Nita; F.J. Carrilho; J.E.M. Medeiros-Filho; J.R.R. Pinho 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Interleukin-28B single nucleotide polymo

Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation

✍ Tomokazu Kawaoka; Shoichi Takahashi; Shintaro Takaki; Akira Hiramatsu; Koji Waki 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB